Our speakers

Dr. Wei Fan is the executive director of Tencent Hippocrates Labs. His main interests are in using various artificial intelligence techniques-based digital therapeutics & digital biomarker for clinical problems, such as motion disorder syndrome (e.g., Parkinson’s disease), cancer radiotherapy planning, heart failure early detection, etc. Dr. Fan received Ph. D. in Computer Science from Columbia University. He has been working in AI since 1995. He has over 150 top journals and conference papers with h-index of 58. He has received multiple best paper awards in top AI conferences and competitions. He served as the associate editor of ACM Transaction on Knowledge Discovery and Data Mining.

Tara Donnelly is the interim Chief Digital Officer at NHS England.

She oversees a portfolio of citizen facing digital services, including the NHS website, NHS App and the development of digital services which meet people’s needs, target prevention and offer a personalised experience.

Tara is on secondment from her role as Chief Executive of the Health Innovation Network. She has led the Health Innovation Network for over three years and is also a non-executive director at the Nuffield Trust.

She has an extensive background in leadership roles within the NHS and the voluntary and community sector and has spent the past 18 years at board level. She has worked in the NHS for 30 years, with her first role being as a Ward Housekeeper when she was 18.

Alan Karthikesalingam is a Senior Clinician Scientist at DeepMind Health, leading the translation between our Health Research and Streams teams. After studying medicine at the University of Cambridge, Alan trained in vascular and endovascular surgery in London, Lille and New York. At St George’s University of London, he completed his PhD and led a successful research group investigating neural networks for medical imaging, new approaches to randomised trials, and the use of routine data to understand care. Alongside clinical practice, he published over 125 peer-reviewed papers, including award-winning first-author studies in the Lancet and the New England Journal of Medicine. Prior to joining DeepMind, he co-launched an app still in use across the London Ambulance Service in a study of vascular emergency Triage.

Prof. Dr. med. Mathias Goyen is currently the Chief Medical Officer Europe for GE Healthcare, a $19billion division of General Electric. Mathias is responsible for leading GE Healthcare’s medical, clinical and evidence generation strategies for product modalities in Europe. Together with his team he provides leadership in healthcare economics and outcomes research and comparative effectiveness research to develop customer value propositions for new and existing products Mathias began his career as a diagnostic Radiologist working at Essen and Hamburg/Germany. He was appointed Professor of Diagnostic Radiology at the University of Hamburg/Germany in 2010. Mathias’previous experience also includes 5 years as Managing Director of UKE Consult and Management GmbH, a subsidiary of the University Medical Center Hamburg where he was responsible for the overall consulting and foreign business of the University Medical Center Hamburg. Together with the leadership team of the hospital Mathias established a Comprehensive Cancer Center linking clinical medicine with new oncologic research strategies. Mathias holds a medical degree from the University of Bochum, Germany. He has been secretary general of the German-Chinese Society of Medicine, Berlin, since 2005. Mathias lives in Essen/Germany with his family.

Stephanie is an NHS Clinical Entrepreneur and Senior Research Fellow at UCL and UCLH where she was awarded a Doctorate in Clinical Research in Oncology. Research Interests include Integrated Data Models for Cancer Monitoring, Survivorship and Longevity. A Clinician-Scientist with over 10 years experience, Stephanie has served on council on a National Cancer Society (BGCS) and is the Healthcare Ambassador of the global organisation Women in AI (WAI). She is a Scientific Advisor to WILD.AI and the Havas Lynx Faculty and on the Advisory Committee of the Social Impact Community, the Conduit, London.

Dr Marc Farr started his career at Experian, where he was head of public sector consulting. He went on to become head of development at Dr Foster, and has been director of information at East Kent Hospitals University NHS Foundation Trust for seven years. He is also founder and chief executive of Beautiful Information.

Beautiful Information is a first of kind NHS / private partnership, that delivers real time information to NHS trusts to help them plan and resource clinical services. It’s vision is to connect patients, clinicians and managers through beautiful information, to make healthcare simple and transparent.

Fernanda is an Ophthalmologist working at two private practices where she is running several studies integrating healthcare and clinical practice to AI. She is also working as a Medical Consultant for Deep Cube’s Glaucoma Algorithm. Fernanda is part of the Surgical Retina Fellowship at HUPE where she also supervises Ophthalmology Medical Residents and is recently running news studies about eye diagnostics with artificial intelligence. 

Frank has always been at the forefront of IT innovation. In his early career he was instrumental in building technological infrastructure in the finance industry. Frank founded TPP in 1997 and pioneered integrated care – delivering his vision of connected care across all health settings. Today, TPP provides leading software that is transforming healthcare worldwide. Frank is active in all aspects of the company’s business operations, working alongside the teams in the development of TPP’s products and representing the company in the public domain.

Frank’s innovative vision is nationally recognised by the NHS, leading journals and healthcare organisations. In 2012, he was elected to the board of TechUK as a spokesperson for the healthcare IT sector. The following year, he was listed as one of the UK’s top 50 innovators in the national health publication, HSJ. In 2015, Frank was named on the Queen’s New Year’s Honours List to be awarded with an OBE (Order of the British Empire), for his services to healthcare.

Frank has been invited on numerous government trade missions, representing the UK health industry around the world. He has visited countries such as China, India and Brazil as part of trade missions led by British Prime Minister, David Cameron and by Kenneth Clarke, QC, MP.

Dr. Amrita Kumar is a Consultant Radiologist at Frimley Health NHS Foundation Trust, with a sub-specialist interest in breast cancer screening. She is leading trust wide research collaboration to implement novel artificial intelligence software for improved patient outcomes. She has been appointed as AI Clinical Lead and is responsible for implementation and adoption of Artificial Intelligence practice within the Trust, working in conjunction with various stakeholders with a mission statement of patient-focused value-based healthcare.

I am a research focussed clinical scientist, working in advanced imaging and image processing for radiotherapy.

My interests include translating cutting-edge methods into routine clinical practice and maximising patient benefit through digital technology, particularly artificial intelligence. Robustness is critical for novel digital technologies in the health sphere, to enable safe and effective uptake of AI.

My clinical work involves imaging patient motion during radiotherapy. Before changing career into radiotherapy I was a chemical physicist working in academic research. I enjoy the outdoors and live in Leeds with my wife and two boys.

Sarah Porter has launched 21 b2b and b2c technology products in 11 countries since 1996 and has a renowned reputation for taking ideas from concept to market with subsequent significant growth globally.

Emerging tech / AI / Medtech / Singularity / existentialism is where her core experience lies and she has over 20 years of commercial experience.

As a board executive for i2i events (parent company The Guardian Media Group / Apax – Ascential – previously Top Right Group) with the specific remit to rapidly grow the business whilst leveraging operational costs and prepare pre IPO. She sat on the i2i mergers and acquisitions committee identifying, analysing and approaching target businesses and accelerated growth by 22% within 12 months.

Achievements include the launch and acquisition of Money 2020 – a leading fintech product. This included negotiation, 3 stage due diligence, its subsequent integration, and the long term geo-adaption into a global portfolio worth over $40m. The launch of World Retail Congress in 10 countries, the re-launch of Cannes Lions festival.

Sarah is a regular keynote speaker on start-ups, business and women / equality related issues and is an ambassador for the Royal Marsden where she champions the use of AI tech in oncology advances.

I am a registered clinical scientist working as a magnetic resonance physicist at Guy’s & St. Thomas’ NHS FT after having graduated from the NHS Scientist Training Programme.

Following a successful NHS Digital Pioneer Fellowship with DigitalHealth.London, I have recently been appointed as Digital Lead for the Clinical Imaging and Medical Physics directorate at my Trust, where we have begun work to develop an evaluation framework for clinical AI.

I am also a part-time PhD candidate at the Centre of Neuroimaging Sciences at King’s College London, developing a machine learning model to better evaluate treatment response in glioblastoma patients.

Sameena Ali-Khan anchors national bulletins for ITV at weekends, and throughout the week on Central Tonight in the Midlands, covering a wide range of stories across daily news and documentaries.

After studying Physiology and Chemistry, Sameena was drawn to journalism. After working on radio in Manchester she first appeared on air on BBC Radio Lancashire. She remained with the BBC, going back to Manchester and GMR before stints on the BBC Asian Network, BBC West Midlands and BBC London, as well Radio 5Live. On TV (aside from a debut appearance made whilst living in Nigeria on the country’s equivalent of Blue Peter) Sameena presented and reported for Northwest Today, Inside Out, and Midlands Today before moving to ITV.

With a presenting style combining bright and approachable with authoritative, Sameena is the only presenter to have won the RTS Best On Screen Personality two years running.

David Chung is the USA Head of Carewell Lepu Medical. A strategic partner of Intel Builders AI program. A patient turned AI technologist, an experienced manager with awareness of the application of digital technology in a range of sectors. David has worked in the healthcare IT sector since 2007, member of ALA, AHIMA leading strategic guidance on data backup, migration, business process outsource, reimbursement audit and workflow optimization.
Prior to Lepu Medical, he oversees millions of medical record data exchange in four States, responsible or $18M P&L as the technology transitioned into artificial intelligence processing. With diverse experience in the artificial intelligence legal services, he’s keen on the possibility of AI.
David is responsible for the global adoption of AI-ECG. And has successfully launched USA’s first AI-ECG enabled telemedicine platform, trained on 47 million patients heart ECG data.
With a sister that suffers from congenital heart disease. David is passionate on expanding the possibility of AI in challenging applications for better patient outcomes.

Joe has worked in healthcare IT since 2004 when he joined the first NHS Spine project as part of the National Programme for IT. He often says that since then he has been making up for the sins of the past. Today he advises everyone from the boards of the central NHS bodies to local charities and healthcare organisations on the best way to approach technology change and the best way to harness its potential to provide actual benefits for patients and health services.

Naomi Lee is a Senior Executive Editor at the leading medical journal The Lancet. She has responsibility for research, leading the development and implementation of the research strategy for The Lancet, and advising on the research content of the other journals in The Lancet family of journals. Naomi handles peer review and commissioning across a broad range of subjects including her specialist areas of surgery, digital medicine/AI, and medical technology. She is also a vice chair for the ITU/WHO Focus Group on Artificial Intelligence for Health.

Naomi joined The Lancet in 2014 and was previously the Executive Editor (Digital) where alongside editorial work she led the internal and external digital transformation of The Lancet group. Previously she studied medicine at Cambridge University and King’s College London, before training in surgery, specialising in urology and working for almost 10 years in the United Kingdom. She has completed fellowships in Argentina, and Mexico. She has also studied data science at University College London.

John manages the clinical aspects of the company’s operations including legislation, information governance, clinical safety and ensuring TPP’s products reflect the latest medical practice.

Dr Parry graduated from the University of Cambridge with a medical degree in 1980. He moved to Yorkshire in 1984 to take a position as a partner of Keighley Health Centre, specialising in oncology and palliative care. He was an early user of SystmOne and recognised the benefits clinical IT could bring to the delivery of patient care. As a result, Dr Parry took the role of clinical lead at TPP, directing the clinical aspects of all products throughout the development process. He holds relationships with leading medical representatives around the country to make sure TPP’s company priorities align with those of the wider clinical community. John became a Director in 2007 and now leads a team of expert clinicians, ensuring TPP’s products meet the requirements of health services.

Dr Parry’s expertise as a healthcare specialist is nationally recognised. He is a member of various high-level committees, including the TechUK Health and Social Care board. As a leading clinician, he is frequently invited to give keynote speeches on a wide range of topics, including information governance and the role of IT in patient care.

Jess (@jessRmorley) is the tech lead for AI in NHSX responsible for developing policies such as the Code of Conduct for data-driven health and care technology, and assessing the readiness of the regulatory framework to cope with emerging technologies. She is also a researcher in the Oxford Internet Institute’s Digital Ethics Lab, and focuses on ‘Governing the Digital Health Ecosystem.’ In both capacities, she is passionate about ensuring ‘society’ is kept-in-the-loop and all people are given a voice in how, when and why data-driven tech is integrated into the NHS and broader health and care system.

Erik de Heus has been at the helm of SkinVision as CEO since 2017. With over 20 years of global experience, Erik has both the breadth of experience and proven knowledge to drive the health tech company’s mission forward.

Throughout his previous work within Hewlett-Packard and Royal Philips Electronics, he has experience building new products and services with a global scope. For Hewlett-Packard, he worked and lived in Geneva and Mountain View. In various management positions, working across cultures with different corporate and entrepreneurial teams, he created and managed different solutions in the technology, finance, services, health, and wellbeing spaces.

In addition to this global experience, Erik was CEO of a Dutch renewable energy company Oxxio. Under his management, the company grew in the timeframe from inception to generate over € 500,000,000. In the buy and build strategy, Oxxio acquired and integrated four companies in two years. OXXIO was acquired in 2005 by Centrica Preventing an IPO planned for mid-2005. Erik holds a Master degree in Business Economics from the Free University of Amsterdam.

Kevin Goodwin is a 32 year veteran innovator from the global ultrasound business. In 1998 he founded Sonosite, the world’s first ultrasound company to miniaturize & simplify ultrasound technology. Today, Kevin is engaged in another first: applying artificial intelligence to recognize anatomy and quickly guide medical practitioners of all skill levels in easily looking into the body, and to make more accurate diagnostic assessments in just seconds. In 2015, Kevin co-founded EchoNous for the purpose of creating intelligent medical tools with extremely miniaturized, diagnostic grade technology.

Emma is an experienced innovation business leader, with proven track record of strategic and operational implementation of innovation methodology, services and cultural change within global small and large organisations. Emma is a collaborative, open communicator with 23 years international business experience, working since 2001 at the forefront of open innovation process development, understanding the importance of organisational, technical and commercial considerations for successful innovation strategy deployment.

Dr Allison Gardner is a Teaching Fellow at Keele University and Programme Director for the Science Foundation Year. She teaches Bioinformatics in the School of Computing and supervises PhD and third year project students. Her research is focused on utilization of machine learning to predict disease, gender and computing, AI ethics and governance of AI.
She works on the IEEE P7000 Global Initiative on the Ethics of Autonomous and Intelligent Systems and specifically P7003 on algorithmic bias, providing a framework for Algorithmic Impact Assessments. Allison speaks nationally on AI Ethics, machine bias and the need for diversity and regulation in the field of AI. She has acted as a consultant for a variety of companies on their AI ethics panels.
Allison is a local councillor and an experienced chair and campaigner. She chairs the Conservation Advisory Working Party, sits on the Economic Development and the Health scrutiny committees and is a school governor. She is an alumnus of the first cohort of the Jo Cox Women in Leadership Programme.

Oliver Smith is the Strategy Director & Head of Ethics at Alpha Health, the health tech Moonshot of Telefónica Innovación Alpha.

Oliver propels Alpha Health’s strategy development, establishing and maintaining strong partnerships to further its mission to deliver breakthrough solutions which address the greatest challenges in the healthcare sector worldwide. In addition, Oliver is the Head of Ethics at Alpha Health, ensuring the total trust of users is at the very centre of the Moonshot’s operations.

Prior to joining Alpha Health in 2016, Oliver worked as the Director of Strategy and Innovation at Guy’s and St Thomas’ Charity, Deputy Director of Health and Wellbeing at the Department of Health and as a Policy Advisor to the Prime Minister’s Strategy Unit.

Christian is Co-founder and Chief Technical Officer of Edge Health. He leads the development of data products that help operational and clinical teams make evidence-based decisions and improve their effectiveness.

Tarek R. Besold, PhD, is the Chief Behavioural Officer at Alpha Health, the health tech Moonshot of Telefónica Innovación Alpha.

At Alpha Health, Tarek offers strategic leadership at the intersection between AI, behavioural science, and the design of digital products. Tarek leads a team of 25 full-time engineers to identify opportunities where behavioural science could be applied to improve or change user behaviour in line with Alpha Health’s strategy and roadmap.

Before joining Telefonica Innovation Alpha, he was a Lecturer/Assistant Professor in Data Science at City, University of London, conducting research at the intersection between artificial intelligence, computational creativity, and cognitive systems.

Among others, Tarek was the General Chair of the HLAI 2016 and 2018 Joint Multi-Conferences on Human-Level Artificial Intelligence, and founder and organiser of several international workshop series bridging between AI and cognitive science. He was co-editor of the books Computational Creativity Research: Towards Creative Machines and Concept Invention: Foundations, Implementations, Social Aspects and Applications. In addition, Tarek holds different editorial functions with several scientific journals in AI and neighbouring fields (including Cognitive Systems Research and the Journal of Artificial General Intelligence).

Tarek also serves as chairman of the German Institute for Standardization (DIN)’s National Working Group on Standards and Norms for AI (part of the ISO/IEC JTC-1 SC 42 “Artificial Intelligence”), and as an expert member of the Digital Future Society’s Think Tank Working Group on “Data Ethics and the Challenge of Digital Privacy”.

Toby Cosgrove, MD, is former CEO and president of Cleveland Clinic. Serving from 2004 through 2017, he led the $8 billion organization to new heights of achievement and efficiency, seeing it ranked the #2 hospital in America (U.S. News). He currently serves as Executive Advisor, working with Cleveland Clinic leadership on strategies for national and international growth.

Dr. Cosgrove graduated from Williams College and the University of Virginia School of Medicine. He trained at Massachusetts General Hospital and Brook General Hospital in London. In 1967, he was a surgeon in the U.S. Air Force, earning a Bronze Star.

Dr. Cosgrove joined Cleveland Clinic in 1975, and chaired the Department of Thoracic and Cardiovascular surgery from 1989 to 2004. He performed over 22,000 operations and earned an international reputation in valve repair He holds 30 patents for medical innovations. As CEO from 2004 to 2017, he reorganized services, improved outcomes and patient experience, and strengthened the organization’s finances.

He is a member of the National Academy of Medicine, and a Fellow of the National Academy of Inventors. In 2016, he was a Fortune Businessperson of the Year (No. 14). Three successive presidents of the United States have consulted him on healthcare issues.

Dr. Peter Lee is Corporate Vice President, Microsoft Healthcare. He leads an organization that works on technologies for better and more efficient healthcare, with a special focus on artificial intelligence and cloud computing. Dr. Lee has extensive experience in managing the process of going from basic research to commercial impact. Past illustrative examples include the deep neural networks for simultaneous language translation in Skype, next-generation IoT technologies, and innovative silicon and post-silicon computer architectures for Microsoft’s cloud. He also has a history of advancing more “out of the box” technical efforts, such as experimental under-sea datacenters, augmented-reality experiences for HoloLens and VR devices, digital storage in DNA, and social chatbots such as XiaoIce and Tay. Previously, as an Office Director at DARPA, he led efforts that created operational capabilities in advanced machine learning, crowdsourcing, and big-data analytics, such as the DARPA Network Challenge and Nexus 7. He was formerly the Head of Carnegie Mellon University’s computer science department. As a thought leader, he has spoken and written widely on technology trends and policies, spanning the fields of computing technology, healthcare, and innovation ecosystem. He is a member of the Boards of Directors of the Allen Institute for Artificial Intelligence and the Kaiser Permanente School of Medicine. He served on President’s Commission on Enhancing National Cybersecurity. He has led studies for the National Academies on the impact of federal research investments on economic growth and testified before the US House Science and Technology Committee and the US Senate Commerce Committee.

Bernardo Mariano Junior is the Director of the Digital Health Department and the Chief Information Officer of WHO. He is responsible for setting and maintaining the vision and direction of WHO’s strategy of health in the digital age. As CIO, he ensures that the digital transformation of WHO enhances the organization’s collective performance and efficiency to deliver the ‘Health for all’ global development agenda.

Prior to joining WHO, Mr. Mariano held senior managerial positions in the International Organization for Migration as Senior Regional Adviser for Sub-Saharan Africa in the office of the Director-General, Chief Information Officer/Director, Information & Communications Technology, and Regional Director for East and Southern Africa.

Trained as a nutritionist, Faculty of Nutrition and Food Sciences, Porto University; Master’s in Public Health, London School of Hygiene and Tropical Medicine. Formerly: worked at national level on developing and implementing health promotion policies with the Ministry of Health in Portugal and the Institute of Preventive Medicine of the University of Lisbon; worked with the World Health Organization Headquarters on global guidelines and policy development for noncommunicable diseases.

Currently, Head of System Initiative on Shaping the Future of Health and Healthcare and Member of the Executive Committee, World Economic Forum. The System Initiative on Shaping the Future of Health and Healthcare provides a dynamic platform for leading businesses, governments, civil society organizations and world-class experts to shape the global health agenda; co-design and accelerate the implementation of collaborative approaches that transform the health ecosystem – across prevention, diagnosis, treatment, cure and maintenance of health; and ultimately enables populations to live healthier lives and have access to the care they need when they need it.

Kimberly Powell is vice president of healthcare at NVIDIA, where she leads the company’s efforts to build healthcare computing platforms that address grand challenges like early detection, diagnoses and personalized treatment.

Partnering with healthcare researchers, startups and industry leaders, her mission is to accelerate the adoption of advanced computing technologies like GPU computing and artificial intelligence.

Powell joined NVIDIA in 2008 as the global business development manager for healthcare. She also served as senior director of AI business development. Prior to joining NVIDIA, she was a product manager for diagnostic imaging at Planar Systems and a hardware engineer at DOME Imaging Systems doing FPGA design.

Powell has a Bachelor of Science from Northeastern University in electrical engineering with a concentration in computer engineering.

Bakul Patel is Associate Director for Digital Health, at the Center for Devices and Radiological Health (CDRH), at the Food and Drug Administration (FDA).  Mr. Patel leads regulatory policy and scientific efforts at the Center in areas related to emerging and converging areas of medical devices, wireless and information technology. This includes responsibilities for mobile health, health information technology, cyber security, medical device interoperability, and medical device software. 
 

Mr. Patel is the FDA liaison between the Federal Communications Commission (FCC) and the Office of the National Coordinator (ONC). Since its inception in 2013, Bakul chairs the International Medical Device Regulators Forum (IMDRF) “software as a medical device” working group, a global harmonization effort.

Before joining FDA, Mr. Patel held key leadership positions working in the telecommunications industry, semiconductor capital equipment industry, wireless industry and information technology industry. His experience includes Lean Six Sigma, creating long and short-term strategy, influencing organizational change, modernizing government systems, and delivering high technology products and services in fastpaced, technology-intensive organizations.
 

Mr. Patel earned an MS in Electronic Systems Engineering from the University of Regina, Canada, and an MBA in International Business from The Johns Hopkins University.

Head of IBM Watson Health for Europe, Middle East & Africa. As the Managing Director, Mark holds full responsibility for the Sales & Go to Market strategy & team, for Watson Health software products and solutions to their customers. This includes the full portfolio of Life Sciences, Oncology, Genomics, Imaging, Government, Value-Based Care & Population Health Management solutions.

Mark has a clinical background and has worked in the NHS as well as many senior leadership positions in global, European and start-up healthcare companies throughout his career, with over 25 years of experience in the healthcare segment, Mark brings a wealth of experience and perspective and he is passionate about health and social care for everyone.

Ann Aerts has been Head of the Novartis Foundation since January 2013, an organization committed to having a transformational impact on the health of low-income populations. Ann holds a Degree in Medicine and a Masters in Public Health from the University of Leuven, Belgium, and a Degree in Tropical Medicine from the Institute of Tropical Medicine in Antwerp, Belgium. In 2014, Ann was nominated by PharmaVOICE as one of the 100 Most Inspiring People in the life science industry. Ann has authored numerous publications and is a member of the Broadband Commission for Sustainable Development, the Governing Council of the UN Technology Bank for Least Developed Countries and the International Advisory Board of the Commonwealth Centre for Digital Health.

Weihong Huang received the B.Eng. degree in automation and M.Eng. degree in pattern recognition and smart control from Southeast University China in 1995 and 1998 respectively and the Ph.D. degree in computer science from Nanjing University China in 2001. From 2001 to 2002, he was a Post-doctoral Research Fellow with the CNRS University Lyon 1 France. From 2002 to 2005, he was a lecturer with the Department of Computer Science, University of Hull, United Kingdom. From 2005 to 2014, he was a senior lecturer with School of Computer and Information Systems, Kingston University London, United Kingdom. Since 2016, he was appointed as a professor and the Depute Director of the Mobile Health Ministry of Education – China Mobile Joint Laboratory, Xiangya Hospital Central South University, China. His research interests include mobile health, artificial intelligence in healthcare, cognitive computing for healthcare, semantic multimedia computing and knowledge graph applications. Prof. Huang is a committee member of China Hospital Information Management Association, standing committee member of the Medical and Health Big Data Evaluation and Assurance board of the Chinese Health Information and Big Data Association, chairman of specialized committee of information management of Hunan Health Management Association.

Roland Rott is the global General Manager of Women´s Health Ultrasound at GE Healthcare, the market leader of Ultrasound for Obstetrics/Gynecology worldwide. The Voluson product line for Women´s Health has been pioneering Ultrasound and AI technology and is touching more than 250 million lives globally every year.

Roland leads the global product organization, consisting of clinical and product management, research & development, installed base customer service, quality management and is responsible for innovation and manufacturing sites in Austria, Germany and Korea.

Before joining GE in 2011, Roland was Managing Director EMEA and Executive board member of Exact Software – a midcap public company headquartered in the Netherlands – leading 4 R&D teams and subsidiaries in 20 countries spanning over Europe/Middle/East, Africa & Asia. In his early career, Roland had an entrepreneurial start, founded two software companies in Austria and successfully sold those to strategic investors.

Roland has a software engineering background, studied International business administration and took executive education courses on strategy and Innovation in Stanford University and the London Business school. He is based in Vienna, Austria and lives there with his wife, two teenage kids and a toddler.

Ramya Palacholla is a Physician and one of the Lead Scientists at Partners Healthcare Pivot Labs. She is also a faculty member of the Harvard Medical School. Currently, Dr. Palacholla works with a multidisciplinary team that develops and executes digital health strategy and research projects in collaboration with top pharmaceutical, research and medical technology companies. She is passionate about her research focused on validation of innovative health technology solutions for improving patient lives. Dr. Palacholla has published her work in several health care journals and presented her research on innovative technologies on international platforms such as the World Economic Forum (also presented at the G8 Summit), served as a reviewer for health technology journals, and spoken at national conferences as a thought leader in the field of health care research and innovation. Her cutting edge research in this area is recognized for its high caliber, and she continues to advance this field to new frontiers. Dr. Palacholla’s idea on an “Innovative Tumor Response Forecasting Model in Breast Cancer Patients” was awarded the first position in the Harvard Ideation Challenge among hundreds of submissions received from across the country. Furthermore, the idea was also selected as one of the top six finalists for the Boston Scientific and Google Connected Patient Challenge, 2018, which is unquestionably a renowned platform that showcases healthcare innovations across the globe. She was also a co-author of one of the first books to be written on proven treatment methods for the management of Military Sexual Trauma and PTSD in war veterans. Following these successes, Dr. Palacholla’s research is well-known in the healthcare innovation space and has given her opportunities to present her research work at national healthcare conferences and summits.

Dr. Shahram Ebadollahi is the Global Head of Data Science and AI at Novartis. In this capacity, he is responsible for defining and shaping the strategy for applications of data science across the pharmaceutical pipeline, from early discovery to manufacturing. He also oversees globally the execution of the strategy and operations of the data science and AI efforts and teams across Novartis.

Before joining Novartis in September of 2018, Dr. Ebadollahi spent 14 years with IBM and had a series of senior executive roles. He was the technical founder of IBM Watson Health, IBM’s first ever business focused on applications of technology and AI to the domain of healthcare and life sciences. In that role, he oversaw innovations, development, and served as the Chief Science Officer of IBM in the area of healthcare. Prior to starting IBM Watson Health, he had started the health informatics research and computational health, with the aim of innovating and applying data-driven and knowledge-driven advanced analytics to the broad domain of healthcare and life sciences. As the Vice President of Health Informatics Research, he oversaw a global team of scientists and innovators in this domain.
One of the latest innovations he started and oversaw before his departure from IBM was applications of blockchain technology to healthcare, which resulted in collaborations with the FDA, CDC and more recently the formation of the Health Utility Network between IBM and a number of health insurance companies and banks.

Dr. Ebadollahi has a PhD and MBA from Columbia University and is a member of a number of scientific and business advisory boards at the intersection of technology innovation, data science and novel business models with focus in the domain of healthcare and life sciences. He has published and overseen graduate level research in the area of analytics for healthcare and has conducted research with funding from national institutions such as NIH. He is a frequent speaker and panelist at events at the intersection of technology innovation and healthcare.

Dr Natalie Banner is the Lead for Understanding Patient Data (UPD), an initiative hosted at the Wellcome Trust to support better conversations about how patient data is used for care and research. UPD works with patients, charities and health professionals to champion responsible uses of data, feeding into policy development, creating accessible resources and horizon scanning for emerging issues that may affect public confidence in the use of health data.

This includes exploring emerging data-driven technologies and how to create the right ethical and governance frameworks for these in healthcare and research. Natalie formerly led Wellcome’s policy work on GDPR and data protection, seeking to ensure UK legislation and regulation creates a supportive, trustworthy environment for health research using patient and health-related data. She was recently named in BioBeat’s “50 Movers and Shakers in BioBusiness” for 2018.

Dr. Alexandra T. Greenhill is one of Canada’s leading physicians in digital health innovation. She is currently the cofounder CEO and Chief Medical Officer of Careteam Technologies, an AI-enabled digital health platform with the mission to solve the fragmentation of health care and enable optimal health.

After having implemented health innovation at scale and practiced medicine in Quebec, Ontario and BC, she now leads and advises Canada’s most innovative technology companies. She is a Global Ambassador for Blackbox powered by Google for Entrepreneurs, an Entrepreneur in Residence at the Health Innovation Boulevard and an advisor and board member to many promising Canadian innovation focused companies. She is the only Canadian to have received the Cartier’s Women Initiative Award, supported by INSEAD and McKinsey and to serve mentor for the Obama Global Entrepreneurship Summit in Silicon Valley. Littlecodr, the game she invented to teach her kids the principles of coding, is now available in 32 countries and top 5 game on the Amazon STEM games list.

Dr. Greenhill has received many recognitions, including Startup Canada’s Woman Entrepreneur of the Year Award, the CMA Joule Award, YWCA Woman of Distinction – Entrepreneurship. WXN’s Top 100 Most Powerful Women in Canada, BIV Top 40 under 40 and the Queen Elizabeth II Diamond Jubilee Medal of Service.

Dr. Dagher is an M.D./Ph.D. who studied Electrical Engineering and Medicine. He is a Neurologist and Professor at McGill University in Montreal (clinician and scientist). His research aims to understand brain reward systems and their role in neurological and psychiatric illness.

He uses brain imaging, notably functional magnetic resonance imaging (fMRI), to map brain activity in response to drugs or natural rewards like food and music. He is particularly interested in figuring out what in the brain makes individuals vulnerable to mental illness. He splits his professional life between clinical neurology and research and teaching. He sees people with Parkinson’s Disease in his clinic once a week. Dr. Dagher teaches medical students and Ph.D. students in neuroscience.

Stephanie is an NHS Clinical Entrepreneur and Senior Research Fellow at UCL and UCLH where she was awarded a Doctorate in Clinical Research in Oncology. Research Interests include Integrated Data Models for Cancer Monitoring, Survivorship and Longevity. A Clinician-Scientist with over 10 years experience, Stephanie has served on council on a National Cancer Society (BGCS) and is the Healthcare Ambassador of the global organisation Women in AI (WAI). She is a Scientific Advisor to WILD.AI and the Havas Lynx Faculty and on the Advisory Committee of the Social Impact Community, the Conduit, London.

Alexander Navarini is a clinical-scientist physician based in Basel, Switzerland. He is a quantitative dermatologist, experimental immunologist and trained in modern genetics.

Born in Basel, raised in Kantons GR and AG, medical studies in Basel and Paris. Training as MD PhD experimental immunologist in Zurich. Residency in internal medicine at Bruderholzspital, tropical medicine at Swiss Tropical Institute, and dermatology at University Hospital Zurich. Senior resident research fellowship in modern genomics at King’s College London. Was attending physician and deputy head of outpatient clinic at Department of Dermatology, University Hospital Zurich. Since November 2018 Chair of Dermatology at the University Hospital of Basel.

Professor Peter Schmid-Grendelmeier was Swiss board certified for Dermatology in 1995 and Allergology in 1997 and became Professor for Allergy and Dermatology in 2003 at the University of Zürich, Switzerland. Since 2003, he has also been the head of the Allergy Unit of the Department of Dermatology of the University Hospital of Zürich.

His research focus is namely atopic dermatitis, urticaria and inhalant allergies; focusing on molecular allergy diagnosis and therapy. In addition he has a strong interest in tropical allergic skin diseases, having worked for several years in Peru and Tanzania. Professor Schmid-Grendelmeier has published more than 150 original articles and is a member of the editorial or review board of several well-established journals.

He serves on the board of various national and international societies. Currently he is President of the Swiss Society for Allergy and Clinical Immunology (SSAI). He is also Director of Education at the Christine Kühne Center for Allergy Research and Education (www.ck-care.ch). Professor Peter Schmid-Grendelmeier also co-chairs the Swiss Expert group for Urticaria and is a member of the EAACI/WAO/AAAAI Urticaria Guideline Board.

Dr Loubna Bouarfa is a machine learning scientist turned entrepreneur.

She is the founder and CEO of OKRA Technologies – an artificial intelligence data analytics company for healthcare. OKRA allows healthcare professionals to combine all their data in one place and generate evidence-based insights in real time, to save and improve human lives. Loubna is currently a member of the European Union High-Level Expert Group on Artificial Intelligence, where she is particularly focused on healthcare and achieving competitive business impact with AI. She was named an MIT Technology Review Top Innovator Under 35, a Forbes 50 Top Women In Tech, and recently won the prize for Best Female-Led Startup at the StartUp Europe Awards. On a personal level, she is a strong advocate for diversity, women and challenging the status quo.

For more information on OKRA, visit ​okra.ai​ and find us on ​LinkedIn​ and ​Twitter​. 

Patrice Matchaba, M.D., has been Global Head of Corporate Responsibility for Novartis since October 1, 2017.

Dr. Matchaba most recently served as Global Head of the Cardio-Metabolic development unit at Novartis, where he led the global clinical development of the cardio-metabolic portfolio. He joined Novartis South Africa in 2000 as the Country Pharma Organization Chief Scientific Officer. Since moving to Novartis Pharmaceuticals Corporation in the United States in 2002, he has held several roles of increasing responsibility such as Therapeutic Area Head for Immunology and Infectious Diseases; Global Head of Drug Safety and Epidemiology; and Global Head of the Integrated Development Functions and Regions, which include Global Clinical Operations, Global Clinical Submissions, Integrated Information Sciences, Development Informatics, Development Diversity and Inclusion, and all Medical Country Pharma Organization regions.

Dr. Matchaba completed his medical training at the University of Zimbabwe, and is a fellow of the College of Obstetrics and Gynecology South Africa. In addition, he is a graduate of Harvard Business School’s Program for Management Development.

Asif Jan leads a multidisciplinary team of scientists specializing in computer science, neuroscience, and statistics. The team implements a variety of statistical and machine learning methods on real-world datasets (e.g. electronic medical records, health insurance claims, disease registries) to fulfill evidence and data analysis needs of the Neuroscience disease area at Roche. Previously, he was Head of Data Science at Roche Diagnostics leading a team of quantitative scientists supporting in vitro diagnostics and clinical decision support product development, where he defined data strategy enabling the use of real-world data. Earlier he has had a number of roles overseeing technology strategy development, enterprise and solution architecture, and program management at Roche and in other research organizations. Asif has vast experience of building and leading data science teams in pharma and diagnostics companies, and industrial research institutes, tackling complex scientific and business problems. He strongly believes that the intersection of strategy, technology and data science is needed to fight diseases, thereby enabling better care for everyone.

Asif holds a PhD in Neuroscience (informatics) from the Swiss Federal Institutes of Technology Lausanne (EPFL), Switzerland, and an MPhil in Computer Science from the University of the West of England, Bristol, UK.

Amandeep Singh Gill joined the Indian Foreign Service in 1992.

He has served abroad at the Indian Mission to the UN and the Conference on Disarmament in Geneva (1994-1996, 2010-2013), the Indian Embassy in Tehran (2001-2004) and the High Commission of India in Colombo (2004-2006). At headquarters in New Delhi, he has served thrice in the Disarmament and International Security Affairs Division (1998-2001, 2006-2010 and 2013-2016) as well as in the United Nations Division (1996-1998). He served as the Head of the Disarmament and International Security Division in the Ministry of External Affairs from 2013 to 2016. He has also served as an expert on the UN Secretary General’s panels of experts on the Fissile Material Cut-off Treaty (FMCT), Small Arms and Light Weapons and on Missiles. He participated in the UN Disarmament Fellowship programme in 1999.

He is the current Chair of the Group of the Group of Governmental Experts (GGE) of the Convention on Certain Conventional Weapons (CCW) on Lethal Autonomous Weapons Systems (LAWS). He is also President-designate of the 2017 Meeting of States Parties to the Biological and Toxin Weapons Convention (BTWC).
Amandeep Singh Gill has a B. Tech in engineering from Punjab University, Chandigarh and an Advanced Diploma in French History and Language from Geneva University. His PhD from the Department of War Studies at King’s College, London is on Nuclear Learning in Multilateral Forums. During 2008-2009, he was a visiting scholar at Stanford University’s Center for International Security and Cooperation (CISAC) on an Asia Foundation regional security studies fellowship. As a scholar he has contributed to the Bulletin of Atomic Scientists, the Lowy Institute, the East West Institute, the Center for a New American Security and the Indian Economic and Social History Review.

Amandeep Singh Gill was born in 1968 in Chandigarh. He is married to Ashma Singh and has a daughter (Bani) and a son (Ujjay). His personal interests include creative writing, yoga and sustainable agriculture. His first book of poems in English was published by Wisdom Tree in 2016.

Charles Alessi is the Chief Clinical Officer for HIMSS International. HIMSS is a global voice, advisor and thought leader of health transformation through health information and technology with a unique breadth and depth of expertise and capabilities to improve the quality, safety, and efficiency of health, healthcare and care outcomes.

As Chief Clinical Officer for HIMSS International, Alessi leads relationship-building efforts among HIMSS’s various international clinician-focused communities; furthering HIMSS’s position as a thought leader in the health industry and supporting both the vision and understanding of information and technology’s roles in the advancement of health and care.

Before joining HIMSS in 2018, Alessi has acted in numerous external positions for governments and executive agencies on a national and international level. Alessi brings more than 25 years of experience in global healthcare policy and clinical practice to HIMSS. Most recently, he chaired the National Association of Primary Care (NAPC), has served as an adjunct research professor for Clinical Neurosciences at the Schulich School of Medicine for University of Western Ontario Canada, and as executive director of the Global International Care Delivery Alliance.

Alessi is also the senior advisor for Public Health England, leading national policy implementation, productive healthy aging and is currently contributing to the global World Health Organization guidelines for dementia risk reduction. Alessi has also contributed his expertise to multiple international publications such as the British Journal of General Practice, addressing topics such as health and social care contract and health policy. He has lectured and led keynote addresses for healthcare engagements taking place on every continent (except Antarctica).

Naomi Lee is a Senior Executive Editor at the leading medical journal The Lancet. She has responsibility for research, leading the development and implementation of the research strategy for The Lancet, and advising on the research content of the other journals in The Lancet family of journals. Naomi handles peer review and commissioning across a broad range of subjects including her specialist areas of surgery, digital medicine/AI, and medical technology. She is also a vice chair for the ITU/WHO Focus Group on Artificial Intelligence for Health.

Naomi joined The Lancet in 2014 and was previously the Executive Editor (Digital) where alongside editorial work she led the internal and external digital transformation of The Lancet group. Previously she studied medicine at Cambridge University and King’s College London, before training in surgery, specialising in urology and working for almost 10 years in the United Kingdom. She has completed fellowships in Argentina, and Mexico. She has also studied data science at University College London.

Liam has a PhD in Medicine. His research is centred on pragmatic trials of telehealth services. Liam has a special interest in the use of telehealth for Indigenous health and rural health care delivery. He is involved in telehealth service development, delivery and evaluation across a broad range of telehealth services, namely, Princess Alexandra Hospital Telehealth Centre, Child and Youth Forensic Outreach Services, eGROW,  Health-e-Regions, DREAMT and the Diamond Jubilee Fund’s Telehealth network. Liam uses implementation research principles to understand why telehealth services work well in some scenarios and not others. He evaluates the effectiveness of telehealth from multi-disciplinary perspectives including clinical effectiveness, patient perspectives, economic aspects, organisational aspects, and socio-cultural, ethical and legal aspects.

Liam also has an active research agenda in health informatics, in particular, in imaging informatics. Liam chairs the metadata group for the International Skin Imaging Collaboration: Melanoma Project. This project is an academia and industry partnership designed to facilitate the application of digital skin imaging to help reduce melanoma mortality – his work promotes the adoption of standards for digital imaging of the skin. Liam has previously been a member of the Standards Australia IT-014 Health Informatics technical committees for telehealth and messaging and communication.

Liam is executive member of the Australasian Telehealth Society and the International Teledermatology Society. He is a member of the Metro South Health Telehealth Advisory Group and a member of the Queensland Health mHealth Apps Working Group. Liam is an editorial advisor for the the Health Information Management Journal.

Liam has 25 years industry experience as a health informatician. His immediate past role was the Manager of Medical Imaging Informatics at the Royal Brisbane and Women’s Hospital. Previously, Liam had over a decade’s clinical experience as a diagnostic radiographer.

Alessandro joined CERN’s Knowledge Transfer Group in September 2018 as Knowledge Transfer Officer for Medical Applications, with the asset of a deep knowledge of the Organisation both in the technology and administrative domains.

Alessandro first came at CERN in 1995 working as experimental particle physicist; then he became fellow in 1999 and staff in 2001, being responsible for a variety of activities in the domains of data acquisition, control and measurement systems for the accelerator and technology sector.

In 2012, Alessandro decided to move to the administration sector to work mainly for the CERN Pension Fund, covering different roles including vice-chair of the Governing Board and chair of the Investments Committee.

Alessandro holds a PhD in Physics (1997) from University of Turin and an MBA (2016) from Guglielmo Marconi University of Rome. He also holds the qualifications of Professional Physics (2019) and Certified Internal Auditor (2017) with a Master on Fraud Investigation (2019).

Sarah Porter has launched 21 b2b and b2c technology products in 11 countries since 1996 and has a renowned reputation for taking ideas from concept to market with subsequent significant growth globally.

Emerging tech / AI / Medtech / Singularity / existentialism is where her core experience lies and she has over 20 years of commercial experience.

As a board executive for i2i events (parent company The Guardian Media Group / Apax – Ascential – previously Top Right Group) with the specific remit to rapidly grow the business whilst leveraging operational costs and prepare pre IPO. She sat on the i2i mergers and acquisitions committee identifying, analysing and approaching target businesses and accelerated growth by 22% within 12 months.

Achievements include the launch and acquisition of Money 2020 – a leading fintech product. This included negotiation, 3 stage due diligence, its subsequent integration, and the long term geo-adaption into a global portfolio worth over $40m. The launch of World Retail Congress in 10 countries, the re-launch of Cannes Lions festival.

Sarah is a regular keynote speaker on start-ups, business and women / equality related issues and is an ambassador for the Royal Marsden where she champions the use of AI tech in oncology advances.

Babita Sharma is a BBC News presenter, regularly seen on the BBC News Channel, BBC World News, and presenting the show Newsday.

Babita has presented the finance programme Your Money, and fronts business reports for BBC News. She has also covered economic and political stories from around the world.

Stefan Germann is CEO of Fondation Botnar, a large foundation in Basel (Switzerland) focused on child health, nutrition and education. He was formerly Executive Director of onegoal.org (an innovative collaborative child nutrition and healthy lifestyle campaign) and Senior Director of World Vision International’s Sustainable Health Partnership, Innovation and Accountability unit based in Kuala Lumpur, Malaysia.

He has worked for more than 15 years in Africa in different leadership roles with various agencies related to child health development, relief and advocacy work. His work included managing a large rural hospital in Zimbabwe. He has held a number of board and advisory board memberships (Partnership for Maternal, Newborn and Child Health, UBS Optimus Foundation, REPSSI in Africa) and currently sits on the Advisory Board of the Global Health Program, The Graduate Institute – Geneva focusing on the role of NGOs in global health diplomacy.

He holds a micro-engineering BSc degree, an MSc degree (Economics) in Social Policy & NGO Management and, in 2005, completed a doctoral degree in Development focused on child wellbeing in an urban African context. In 2015, Stefan graduated from the Executive Masters program in Tri Sector Collaboration at Singapore Management University.

Jaquie is Head of Digital Health at Cambridge Consultants and leads the initiative to provide strategic guidance and technical solutions for clients transitioning their business model to include a digital element. These digital elements include device connectivity, AI, security, launch strategies, behavioural science and digital service design.

Jaquie has previously worked on the design and launch of a compliance & work management IoT service that is in commercial use. She has a BSc in Applied Biology, 10 years’ experience in Molecular Biology and 15 years’ experience of Product Management and Marketing for software, hardware and digital services in medical and life science industries that include immunology, ophthalmology, neuroscience and bioinformatics.

Jaquie is a member of the Chartered Institute of Marketing (CIM).

Christopher has over 20 years of experience as a technology entrepreneur and business advisor, having worked for many Blue-Chip organisations helping solve their critical global scale data problems.

Highlights of his career:

• A client was awarded Innovative Business of the Year based on his innovative technology to manage a very large multi-lingual outsource for British Airways.
• Christopher developed what became best-in-class global forecasting models for Nokia for several years running. It was quoted as being “second to none” according to the Financial Times Lex column at the time.
• He developed a new target operating model for a large UK Pharma helping to decrease overall inventory by $750m.
• He set up drug pipeline budget management capability for a large European Vaccines company with a budget of over €500m.
• Master data and data governance monitoring and management system was specified designed and implemented by him for a large pharmaceutical client.
• As Head of EMEA Life Sciences for CSC he was awarded CSC Ingenious Mind with Dr Robert Wah.

Christopher has also been a strategic advisor for the W3C and works with start-ups on innovation in the human-centric web. He has an agile innovative mind-et derived from a wealth of problem-solving for customers and the ability to adapt to the needs of the customer. AI and data are the lifeblood of Volv and Christopher is excited to be bringing their cutting-edge offerings to market.

In June 2015, Dr. Baher Al Hakim started Medicus AI, an AI-based platform that explains and interprets medical reports and health data, turning numbers into meaningful insights.

Baher is a dentist by study and a serial entrepreneur by practice, with 15 years experience in a broad spectrum of disciplines including product & technology, business, sales and marketing.

Some of his previous companies include digital agency, napkin startup studio, and Wally, a smart personal finance app that became no. 1 finance app in 22 countries.

Dr. Fred Jordan is co-founder of AlpVision and has served as CEO since June 2001. He is the author of numerous scientific publications and patents and co-inventor of Cryptoglyph and Fingerprint, AlpVision’s core technologies. Dr. Jordan has work experience in the United States and in France. In 1999, he received his PhD from the Swiss Technology Institute (EPFL) – Signal Processing Institute (ITS) in Lausanne.

Frédéric Dayan, 40 years old, is the founder of ExactCure, a company that aims at simulating your personalized response to drugs thanks to digital models. His dream is to build your perfect virtual avatar in a mobile application. Imagine how this virtual copy of yourself could help you optimize your health!
Frédéric is a former Research & Development (R&D) team leader from the Dassault Systèmes software editor. He is expert in modeling for Life Sciences. He received two Doctorates (Pharmaceutical Science + Cancer Research), and a Physics Engineering diploma from the “Ecole de Physique et de Chimie de Paris”.

After an academic career in bio-modeling as a researcher and teacher at the University of Nice Sophia Antipolis, he decided to manage teams in private R&D, both for small and big industries. Now he is creating his own company in order to bring his vision to life: a world where patients and health professionals would benefit from cutting-edge technologies in modeling and simulation.

Maxine Mackintosh is the co-founder of One HealthTech – a community which champions and supports underrepresented groups in health innovation, particularly women, to be the future leaders in healthcare. She does this alongside a data science PhD in London where she is mining medical records for new predictors of dementia. Her professional work has led her to the Royal Society, Roche, L’Oreal, Department for International Development, and NHS England. She is part of a number of communities and committees including the World Economic Forum’s Global Shapers, the British Computer Society and the Digital Health Forum. She really really likes fancy dress.

Marcin Pietrzyk is the founder and CEO of Unit8, the company bringing world-class experts with a proven track record in AI and Software Engineering to solve problems for industries that will experience the most significant breakthroughs in the next 50 years. He was the visiting lecturer at the University of St Gallen for EMBA and Certificate of Advanced Studies (CAS) in digitalisation.

Before that, he was the Head of Network Intelligence and then Head of Big Data & BI at Swisscom. He completed his PhD in Orange Labs, Sophia Antipolis, France in the domain of data mining and machine learning in the context of IP networks intelligence.

Graduated from Carnegie Mellon and Harvard Business School with degrees in information technology, finance, and business administration, Dennis has more than 10 years of experience in financial and strategy consulting in the medical device and IT sectors. Originating from a family of surgeons tracing back three generations, he possesses a keen awareness of the impact that new technologies can bring to surgical innovation. Dennis has a vision to expand the caresyntax® product and operations to new heights and new markets. He understands the challenges of the digital health industry, having co-founded and run two companies himself before co-founding caresyntax®.

Christophe Hsu is a dermatologist trained in Geneva, Switzerland and Singapore. Currently in private practice (since 2010), he is a consultant of Teledermatology and Artificial Intelligence at the University of Basel, as well as a Special Editor to the JAAD and section Editor to the JEADV. His special interests are: Teledermatology and AI in Dermatology, Social Media in Dermatology.

Peter Speyer is Head of Products, data42 at Novartis, responsible for implementing data and analytic products in a transformational program that leverages data from across R&D for machine learning and AI. Before data42, Peter led teams to develop platforms to collect, manage and analyze data as Head of Digital, Medical and Real World Evidence Solutions. Before Novartis, Peter was Chief Data & Technology Officer at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington in Seattle. He was responsible for data and IT for high-profile analytic projects like the Global Burden of Disease (GBD) study, including obtaining and managing data from 190 countries, running high performance computing infrastructure, and creating IHME’s global public data catalog Global Health Data Exchange (GHDx) and innovative interactive data visualizations.
Prior to joining IHME, Peter worked in strategy and product management in the media industry, including Corbis and Bertelsmann. He holds an MBA from Temple University in Philadelphia, USA, and a Master in Business and Engineering from the Karlsruhe Institute of Technology, Germany.

Dr. Enes Hosgor, a systems engineer by training and former Fulbright Scholar, is a Carnegie Mellon-educated serial AI entrepreneur. Based on his Ph.D. work at Carnegie Mellon, where he has taught on technology commercialization topics, he founded a Pittsburgh-based AI company which got acquired in 2018. In addition to his consulting background, Dr. Hosgor also worked in venture capital, namely, for Foundation Capital and New Venture Partners – the former venture arm of The Bell Labs. His penchant for healthcare stems from his family of physicians including his wife, sister and late father.

Lina works at the intersection of engineering, data science and healthcare. Previously, she was the COO of Enlitic, a startup that uses deep learning to improve clinical diagnostics in medical imaging. Before this, she was the Innovation Director at one of the largest centers at the University of California, Berkeley, where she helped scale and spin out new social-impact technologies. Lina has also been recognized on MIT Technology Review’s “TR35” annual list of the world’s top innovators for her work in open science. Her writings have been published in the New York Times, Washington Post, Science, and Make Magazine. Lina has a PhD in biomedical engineering from the ETH Zurich. When she is not doing science, she likes to ski, run and backpack.

Dr. Christof Bühler, Dept. Head Life Science and Physics, Supercomputing Systems

Since 2009 Christof Bühler leads the department «Life Science and Physics» at Supercomputing Systems AG. The focus is on developing innovative hardware and software solutions for industrial and academic partners in biotechnology, medical diagnostics, electronic engineering and applied physics by combining multi-disciplinary R&D expertise and professional networks.

Christof Bühler has 25+ years of engineering & research experience in electronics, software, vision & sensor systems, optics, lasers and micro-technology. His inter–disciplinary expertise is in system integration, computer/information technologies, biotechnology, medical devices, sensors, computer vision, fast data processing and artificial intelligence incl. machine- and deep-learning.

Samira Rahimi Eng. Ph.D. is an Assistant Professor in the Department of Family Medicine at McGill University. She is affiliated scientist at Lady Davis Institute of the Jewish General Hospital, Director of Artificial Intelligence in Family Medicine (AIFM) research group of McGill, and regular member of Cardiometabolic Health Diabetes and Obesity research network, Institute of Electrical and Electronics Engineers (IEEE), and Association for the Advancement of Artificial Intelligence (AAAI). She is recipient of numerous scholarships, fellowships and awards among them the 2015 Canada Women in Engineering award of IEEE.
She has worked on several Artificial Intelligence(AI)-related projects in different contexts, and currently is leading an international Canadian Institute of Health research (CIHR)-funded project on effective use of AI in Community Based Primary Health Care.
With an interdisciplinary background, Dr.Rahimi is interested in development, evaluation, and implementation of clinical decision support systems and patient decision aids, as well as integrating human-centered and explainable AI systems in health care. She specializes in computational intelligence, decision sciences, applied operational research, shared decision making and patient oriented research.

Alexander is a co-founder of Nye, an early stage healthcare company with a big dream to build a health system which maximises welfare and an individual’s ability to flourish. He is also a practising primary care physician and on the faculty at Oxford University. He was previously a Kennedy Scholar at Harvard University where he studied System Biology and Genetics and was the Head of Research at the King’s Centre for Global Health. In 2008, Alexander started an award-winning health technology company which delivers health system capacity building in fragile states, with a particular focus on Somalia. Most recently MedicineAfrica and partners were awarded the first of UKAID’s flagship global Higher Education programme, Strategic Partnerships in Higher Education Innovation and Reform (SPHEIR). He likes to ski and plays the bagpipes.

Elena Bonfiglioli, Managing Director Health and Life Sciences, Microsoft EMEA
Elena Bonfiglioli leads the Health and Life Sciences Industry business for Microsoft in Europe, Middle East and Africa, and is part of the World Wide Commercial Business Team. She is responsible for driving strategy and business development, partnerships, and positioning for the region across public health, social services, providers, and pharma. Elena is an advocate for the transformation of healthcare systems with Cloud and AI.

Bart Geerts is CEO and Founder of Healthplus.ai, a growing AI startup based in Amsterdam. He has a background as a cardiac-anaesthetist, intensivist and clinical pharmacologist. He is also an associate professor and co-supervises a team of researchers at Amsterdam UMC. His focus with Healthplus is to enable patients and health care professionals to be more proactive in their management of disease and health by using existing data and machine learning. Bart also has an MBA from IE University in Madrid, worked in hospital administration, and still does clinical work every week.

Yair Benita leads scientific operations at CytoReason, heading a team of exceptional immunologists, biologists and bioinformaticians focused on discovering novel targets, indications, combinations and biomarkers from data using molecular-level models of disease. He is a computational biologist with deep expertise in drug development. He joined CytoReason from Compugen, where, as Head of Computational R&D, he led discovery of novel drug targets through a computational Predictive Discovery process, successfully discovering several novel immune checkpoint inhibitors for cancer immunotherapy, including the first in class target PVRIG. Yair holds a Ph.D. in Bioinformatics, from Universiteit Utrecht, followed by a research fellowship in computational biology at Massachusetts General Hospital, Harvard University Medical School.

Philipp is a Founder and Managing Director at FYRFLY Venture Partners, an early stage venture firm based in San Francisco and close connections to Europe.

Philipp brings a deep track record as an investor, entrepreneur and consultant of building and accelerating technology businesses across vertical markets including health tech. Over the course of a 20+ year career, Philipp has served as a strategic advisor and investor to early stage start-ups, Fortune 500 companies and technology leaders such as Google, Salesforce, Facebook, VMWare, Splunk and Accenture. Philipp was a founding managing partner at Accenture Interactive and he was a driving force in Accenture’s early cloud initiatives including the billion-dollar partnership between Salesforce and Accenture. He was also part of Accenture Technology Ventures (ATV), building and executing on an extensive technology venture portfolio in the U.S., Europe and Asia. Philipp started his career with Vontobel Asset Management in public fund management as part of a leading Swiss private bank, and subsequently advised global brands such as Ikea, Nestle, Novartis, P&G, Lindt, L’Oreal and others as part of Interpublic (IPG).

Philipp holds an MBA from The Wharton School, University of Pennsylvania, and a B.A. in Micro Economics, University of Applied Sciences, Zurich, Switzerland. Philipp is based in Silicon Valley, California.

Dr. Anurag Agrawal took charge as director of CSIR Institute of Genomics & Integrative Biology (IGIB) on 25th October 2017. He graduated in medicine from the All India Institute of Medical Sciences in 1994, followed by specialization in Internal Medicine, Pulmonary Disease, and Critical Care from Baylor College of Medicine, Houston, (2003) and a PhD in physiology from Delhi University. After serving as a faculty member of the Department of Medicine at Baylor, he joined IGIB in 2007, where he established the Centre of Excellence for Translational Research in Asthma & Lung disease (TRiAL) and the CSIR program for Effective Application of Community Health efforts through new age Information Technology (EACH-IT). His research activities include use of experimental and computational model-systems to study disease, especially asthma. Dr Agrawal believes health data analytics, with artificial intelligence applications, to be the new frontier of medicine and is actively engaged in promoting the confluence of medicine and informatics. He has more than 100 scientific publications, mostly original research findings communicated in high-impact journals. He has been recognized internationally, as an alumnus of Kavli Frontiers of Science program of the US National Academy of Sciences, as well as nationally in the form of the Shanti Swaroop Bhatnagar award (Medical Sciences, 2014), National Bioscience award (2015), Wellcome Trust DBT India Alliance senior fellowship (2015), Lady Tata Young Researcher Award (2010) and the Swarnjayanti Fellowship of the Department of Science and Technology (2010). Dr. Agrawal is a member and fellow of numerous academic societies and serves on advisory bodies at Public Health Foundation of India, Lady Tata Memorial Trust, Centre for Cellular & Molecular Biology, Centre for Brain Research, and Indraprastha Institute of Information Technology, amongst others, as well as an advisor for start up companies and healthcare organizations.

Eyal Toledano is co-founder and CTO of Zebra Medical Vision; Eyal focuses on innovation in medical imaging machine vision. Graduated with Master of Science from the MIT Media Lab. Eyal served for more than 8 years as the CTO and Advanced Technology GM for Samsung Israel R&D (STRI/Yakum). Before co-founding the Israeli R&D of Samsung Eyal was leading the development of challenging projects at Sun Microsystems. Eyal completed 7 years of military service in the IDF Elite Intelligence Technologies. Eyal still hacks code every day and enjoys making morning sandwiches.

Magnus Conteh joined the Last Mile Health team in 2018 to help lead the Community Health Academy, which aims to reinvent the education of community health workers – and the health system leaders who support them – for the digital age.

Magnus brings over 25 years of senior level experience in education, global health, and digital health to Last Mile Health. Previously, Magnus worked for seven years at World Vision Ireland, most recently serving as the Deputy CEO/Director of Programmes and Strategy. Notably, he led World Vision’s involvement in the Johnson & Johnson/Janssen Ebola Vaccine trial in Sierra Leone, which included overseeing the deployment of technology critical for the clinical trial. In addition to serving as a member of the World Vision International Digital Health Steering Committee, he forged multi-stakeholder collaboratives and digital health partnerships with a number of governments, mobile network operators, and other INGOs in Africa.Prior to joining World Vision Ireland, he held a number of senior management positions in the National Health Service in the UK and the Health Service Executive in Ireland, where he served as Director for the Regional Centre of Nursing/Midwifery Education at the University Hospital in Galway. Magnus holds a Masters of Health Science (Hons) in Health Services Research from the National University of Ireland, Masters of Arts in Health Service Policy and Management from Brunel University (UK), and a Postgraduate Diploma in Management Studies from Kingston Business School at Kingston University (UK).

Dr. Oliver Morgan is the Director of the Health Emergency Information and Risk Assessment Department in the WHO Health Emergencies Program. From 2007 through 2016, Dr. Morgan worked for the US Centers for Disease Control and Prevention during which time he held critical leadership positions in the Ebola response between November 2014 and February 2016 (CDC Atlanta Ebola Response Incident Manger and CDC Country Director in Sierra Leone).From March 2010 to October 2014, Dr. Morgan was the CDC Country Director in the Dominican Republic. Dr. Morgan was an Epidemic Intelligence Service Officer at CDC from 2007 to 2009 with the International Emerging Infections Program, during which time he conducted projects in Thailand, Bangladesh, Kenya, Uganda, and Guatemala. Before joining CDC, Dr. Morgan worked for the UK Health Protection Agency, leading epidemiological investigations of outbreaks (enteric, vaccine preventable, hospital acquired, zoonotic, respiratory, and sexually acquired infections), chemical and radiation exposure incidents, terrorist bombings in London, natural disasters, and humanitarian civil conflicts. Dr. Morgan has also worked as a consultant to WHO/PAHO in several countries. Dr. Morgan’s academic achievements include a doctorate in epidemiology from Imperial College London and extensive publication in peer reviewed journals and reference books.

After graduating med school, Tamir served as a physician in the Israeli Navy SEALS. During his tenure, he was awarded the Medal of Distinguished Service for treatment of wounded under fire. Transitioning to civilian life, Tamir found his passion on the industry side of healthcare and worked in various leadership positions in startups and as a VC. He co-founded theator after witnessing firsthand the unacceptable variability and disparity in surgical care. Tamir holds a MD and PhD from the Technion and completed the executive MBA program at Harvard Business School.

Dr Lim Xinhong joined Vickers in 2015 and is based in Silicon Valley. He has led investments into drug delivery, AI drug discovery and advanced materials companies, and advises on fund strategy and portfolio companies in the life sciences, healthcare and tech sectors.

Dr Lim obtained a Certificate in Innovation and Entrepreneurship from the Stanford University Graduate School of Business. He is an Assistant Professor (Adjunct) in skin stem cell biology at the Lee Kong Chian School of Medicine, Nanyang Technological University (NTU) and the Skin Research Institute of Singapore (SRIS) at the Agency for Science, Technology and Research (A*STAR).

Dr Lim received his Ph.D. in Developmental Biology from Stanford University under the tutelage of Breakthrough Prize winner Professor Roel Nusse, a pioneer of Wnt signalling biology. Lim has been the lead Principal Investigator on more than $15 million of research grants funding his work on stem cell regulation and skin biology. His work on Wnt signalling and stem cells has been published and cited in the most prestigious scientific journals, including Nature and Science, as well as highlighted in the international press, including by CNN and BBC. He is the recipient of numerous awards, including the Singapore National Academy of Sciences Young Scientist Award, the Ten Outstanding Young Singaporeans Award (Medical Innovation) and the A*STAR-IMB Investigatorship in Skin Biology. Lim is fluent in English, Mandarin and Cantonese, and has a working knowledge of French.

Martin Ciupa currently works at Mindmaze as Head of AI Initiatives / CAIO, based out of their HQ (Lausanne, Switzerland). He has worked as a senior manager in AI/Cybernetic & Robotic systems and IT&T solutions based primarily in Europe, the Americas and Asia. These roles encompassed both technology and commercial roles at an executive level, e.g., Regional VP for Agilent and British Telecom. His most recent position was CTO of Calvary Robotics Software Division (calvIO), developing intelligent automation systems. Academic background: Physics and Cybernetics, and has been published in international journals and conference proceedings, including in the past year presentations to the EU, Keynote address to the Robotics Industry Association, Boston Harvard Medical School/Forward Leading Big Data & AI conference, the Berlin “Rise of AI conference” and the United Nations SDG Health Summit. The Agilience Authority Index has rated Martin as a top 100 authority in AI, ML, Speech Recognition and NLP. Thomson Reuters rates Martin in the top 25 of social influencers in Risk, Compliance, and RegTech in the United States. You can check him out further on his well viewed TEDx, and social media where he has more than 80k followers.

Frank has always been at the forefront of IT innovation. In his early career he was instrumental in building technological infrastructure in the finance industry. Frank founded TPP in 1997 and pioneered integrated care – delivering his vision of connected care across all health settings. Today, TPP provides leading software that is transforming healthcare worldwide. Frank is active in all aspects of the company’s business operations, working alongside the teams in the development of TPP’s products and representing the company in the public domain.

Frank’s innovative vision is nationally recognised by the NHS, leading journals and healthcare organisations. In 2012, he was elected to the board of TechUK as a spokesperson for the healthcare IT sector. The following year, he was listed as one of the UK’s top 50 innovators in the national health publication, HSJ. In 2015, Frank was named on the Queen’s New Year’s Honours List to be awarded with an OBE (Order of the British Empire), for his services to healthcare.

Frank has been invited on numerous government trade missions, representing the UK health industry around the world. He has visited countries such as China, India and Brazil as part of trade missions led by British Prime Minister, David Cameron and by Kenneth Clarke, QC, MP.

Prior to joining XPRIZE, Mr. Banifatemi began his career at the European Space Agency and then held executive positions at Airbus, AP-HP and the European Commission division for information society and media. He managed two venture capital funds and contributed to the formation of more than 10 startups with emphasis on Predictive Technologies, IoT, and Healthcare. Mr. Banifatemi is a guest lecturer and an adjunct MBA professor at UC Berkeley, Chapman University, Claremont McKenna College, UC Irvine, and HEC Paris.
He holds Masters degrees in Electrical Engineering from the University of Technology of Compiègne, a Doctorate in System Design and Cognitive Sciences from the University Paris Descartes, as well as an MBA from HEC Paris.

Daniel Diezi heads the Life Sciences & MedTech sector at Zühlke and assumes the commercial responsibility for projects in this area. He keeps pace with changing global trends in the healthcare sector and leads the strategic development of Zühlke’s health offering. Previously, he worked at a medical device company in different positions, initially as Global Product Manager, before accepting the role as Area Director APAC & North America. Daniel led the department responsible for strategic business development, global sales and geographic market expansion. With more than 10 years of global healthcare experience, Daniel Diezi already led digital transformation projects internationally within the MedTech industry before he joined Zühlke. He holds degrees in mechanical engineering and business administration and completed executive programs at the IMD in Lausanne and the Ashridge Business School in London.

Alodeep Sanyal is an Indian American computer scientist and currently serves as the co-founder and CEO of LifePlus, Inc., a silicon valley startup leading the path to the world’s first ever non-invasive continuous glucose monitoring wearable solution. Alodeep is a semiconductor industry veteran and played leading roles in developing next generation server products for Intel Corporation before switching to his current stint at LifePlus. He is considered a thought leader in the domain of deep-health wearable products and speaks extensively at the leading conferences and meetings in the broad domain of wearable and health & wellness technologies. Alodeep is a senior member of IEEE. He received a master of science in computer science from Colorado State University, Fort Collins and doctor of philosophy in computer engineering from University of Massachusetts, Amherst.

Dr. Hugh Sturrock is an Associate Professor of Epidemiology and Biostatistics working in the Malaria Elimination Initiative (MEI) in the UCSF Global Health Group and is lead of the Disease Surveillance And Risk Monitoring (DiSARM) project. Prior to joining the Global Health Group, he completed a MSc in Zoology at the University of Otago, New Zealand studying avian malaria in yellow-eyed penguins and a PhD at the London School of Hygiene and Tropical Medicine, investigating optimal survey methods for Neglected Tropical Diseases and malaria. He has a broad interest in optimizing surveillance methods for tropical infectious diseases, with his research to date involving a combination of field work and statistical analyses. He is particularly interested in the use of statistics, machine learning, mapping and digital technology to help solve problems facing disease programs. He has worked in a number of countries, including Kenya, South Sudan, Yemen, Namibia and Swaziland.

Hugh also teaches and mentors students at UCSF, is course director for a new online Spatial Epidemiology course at UC Berkeley and has served as co-supervisor for students at the University of Namibia. He also serves as an advisor for the Global Health Corps, supporting fellows placed in public health programs throughout Africa.

Hugh’s work has been featured in numerous peer-reviewed publications as well in media articles in The Guardian, BBC, New York Times and the San Francisco Chronicle. Hugh and the DiSARM project were also featured on a PBS Newshour segment.

Dr Jacqueline Jacques, D.Sc. has more than 40 years of experience as Manager, Management Consultant, and more specifically, she has been a well-reputed Coach & Trainer of Quantum Biofeedback & Bioresonance for more than 14 years using the EDUCTOR, the ultra-sophisticated new AI generation of Biofeedback device.

As President of BioQuantique SARL, she lectures and leads seminars in various parts of the world, on the multiple possibilities of the Quantum Technologies to promote a paradigm shift in Health & Wellness based on the new scientific discoveries of Quantum Physics, Biofeedback & Bioresonance. She enjoys coaching & training therapists in the optimal use of these technologies, while continuing researching about Quantum Energy Medicine. She developed her concept of “Technologie-based BioQuantum Wellness Center” as a new approach to Prevention, Healing & Anti-Aging.
She is part of those visionaries who dare to make a «Quantum Leap» into the new Quantum World adapted to our 21st Century!

Milosz Wicinski is a Business Development Manager at Infermedica, which is one of the leading Artificial Intelligence health companies that improve the process of medical diagnosis. Infermedica’s goal is to increase healthcare accessibility, minimize the rate of misdiagnosis and streamline costs of providing quality care. The company’s products (Symptom Checker, Call Center Triage, Medical API) have been used by over 3.5 million users worldwide and are offered in a B2B model to health insurance companies and health systems. Milosz is a young professional passionate about technology, digital health, clinical decision support, and startups. In his work, Milosz is helping Infermedica to deliver tailored AI medical solutions to partners all over the world.

Dr. Longmire is a Stanford-trained physician and entrepreneur driven to improve human health through advances in technology. Dr. Longmire founded Medable in 2015 to enable healthcare technology to be as seamless, integrated, and adaptive as the human body. Medable is transforming healthcare by enabling patient generated data to drive healthcare delivery, clinical research, and personalized and predictive medicine.

Frederike is a Neuroscientist at the Translational Neuromodeling Unit (TNU) at the University of Zurich and ETH Zurich. Before coming to Zurich, Frederike obtained a M. Sc. Hon. Degree in Physics, followed by a PhD in Neuroscience at the Graduate School of Systemic Neurosciences at the LMU Munich and the Bernstein Center for Computational Neuroscience in Munich. In her research Frederike combines computational models of learning, decision-making and perception with measurements of human behavior and brain function (EEG & fMRI). In her work she focusses on studying the perception of the body (interoception) and reward and structure learning in the context of psychosomatic disorders, addiction and Obsessive-compulsive disorder. Her aim is to translate neuroscientific research into useful applications that promote mental health, support individualised diagnosis and enable targeted treatment for mental disorders.

Founder and chief innovator of Cardio-Phoenix Inc, Marc has a history of successful ventures. His biggest success was the sale of his first major company to a large corporate entity, afterwhich he spent two years as VP of Business and Product Innovation for the Carrier Division. He was also responsible for the growing the Asian market and showing them how to monetize their offerings. He then retired only to come out of retirement after several friends suddenly, in their 40s, tragically passed away from undetected heart disease, revealing a gap in medical technologies between what was available in primary care and cardiology care. A chance meeting in San Diego with 5 terminal heart patients, encouraged him to pursue his heart device vision – they understood the problem. He then spent over a decade developing 6 different versions of his technology, conducted many clinical studies to gather his evidence and embracing the regulatory regimes dominating the heartcare market. He is the driving force behind their AI strategy, embracing the most innovative frameworks and conducting their own AI innovations.

Dr. Darren Gates is a senior Registrar in Paediatric Intensive Care at Alder Hey Children’s Hospital, Liverpool, UK. In addition to his clinical practice he works as a Clinical Innovation Consultant in the Trust’s award-winning Innovation Hub where he is clinical lead for the artificial intelligence workstream. This includes The Living Hospital project, a partnership with the Science and Technology Foundation Council’s (STFC) Hartree Centre and IBM, working to improve patient care and experience.

For the past 11 years, Jay has been building services that explore what the internet means to healthcare delivery. Two months after the iPhone was released back in 2007, he launched the world’s first mobile-powered house call doctor practice and it subsequently went viral racking up 7 million hits on his site in the first month of operations. Soon after, he co-founded Hello Health, one of the first cloud-based electronic medical records designed to power a new kind of medical practice— one that delivered care both in their offices in NYC and online with their patients. Hello Health continues to thrive powering cutting-edge practices around the world.

In 2010, he co-founded a design firm to work with large brands across the world to help them figure out what the internet means to health. His clients included the NHS in the UK, Sanofi in Paris, Planned Parenthood of America, and Physicians Interactive. With Physicians Interactive, they ideated and designed one of the most popular iPad apps for physicians, Omnio.

In 2012, he created Sherpaa and pioneered Virtual Primary Care. VPC combines the scalability and accessibility of telehealth with the continuity found in traditional primary care and enables primary care doctors to manage 95% of the conditions a traditional office-based primary care doctor can manage. Sherpaa employs full-time physicians and delivers 24/7/365 primary care in 48 states to employees of self-funded companies, members of forward-thinking health plans, and directly to individuals.

Jon Sorenson, Ph.D., is head of the cheminformatics team at Atomwise. Jon has nearly 20 years of experience in computational biology and software leadership, ranging from senior contributor roles to executive management of 100+ person teams spanning computational biology and software operations. He has held senior leadership roles at Applied Biosystems, Pacific Biosciences, Invitae and 10X Genomics, and he is co-author on more than 30 publications and patents. At Atomwise, Jon is thrilled to have returned to his first passion of computational drug design, a field that he first encountered as a college intern working at Merck Research. Before joining industry in 2000, he obtained a Bachelor of Science in chemistry and mathematics from Harvey Mudd College, a Master of Philosophy in theoretical chemistry from the University of Cambridge and a Doctor of Philosophy in computational chemistry from the University of California, Berkeley.

Fabien Astic is Co-Founder and Chief Business Development Officer at ExactCure, an innovative startup developing your Digital Twin that simulates in silico the effect of medicines in your body based on your personal characteristics.

He has 20 years of experience in new technologies among both startups and large companies. His previous position was head of the EIT Digital Accelerator France – an institute funded by the European Commission. Prior to that Fabien was VP Sales for another startup, after he had been called to join the Corporate Sales Operations team of Technicolor. He started his career as Software Developer at Alcatel-Lucent and spent some time in the Silicon Valley and Germany.

Fabien holds an INSEAD MBA, a M.Sc. in Electronics & Engineering with Honors from the University of Glasgow, and an engineering degree from the Grenoble Institute of Technology. »

David Lapointe is a serial entrepreneur in the life science industry. He has extensive experience in company start up, technology development, financing and sales.

David started his career in Sales and Marketing positions in the pharma industry. In 2001, David founded Advanced Molecular Imaging to bring molecular imaging technologies to the global pharma and research market. He went on to hold the position of Global General Manager for Molecular Imaging and Research at GE Healthcare. At GE David was responsible to drive Global sales and product development of diagnostics imaging. David co-funded and managed lifescience and IT companies in which he was responsible for driving strategic thinking and to accelerate progress against specific agenda.

David currently serves as CEO of Optina Diagnostic. Optina is applying AI to spectral retinal imaging to identify candidate for pharma clinical trials. In his, role David as raised over 12M$ in financing. He is also key business advisor to BVc Amsterdam radiopharmaceutical, advisor investors in Facten and Bio-innov.

A seasoned campaigner in finance and technology, Thomas is passionate about bringing growth to innovative companies with exciting technologies that have the potential to help millions of people worldwide. He combines a background in science with a PhD from the University of Glasgow and an MBA from the University Cambridge, and has worked in the development of data technology companies as well as working in corporate structuring, financing and venture capital in a number of industries including biotechnology, developing novel drugs for Alzheimer’s and Parkinson’s disease, and medical technology. He is also a guest lecturer in corporate finance and entrepreneurship in the pharmaceutical industry at University College London. Thomas is currently the Chief Operating Officer of Cognetivity Neurosciences and with the Cognetivity team is working on delivering a cutting-edge AI driven platform that is capable of detecting the earliest signs of cognitive impairment, which has the potential to help to solve massive global crisis around failures in the early diagnosis of diseases such as dementia.

Lynda Brown-Ganzert, BSc, MEd. is the CEO of Curatio – a privacy and regulatory compliant social platform used in over 85 countries that combines AI and matchmaking to deliver private peer networks to patients and their families. These networks provide social support, disease education and daily management tools that support adherence and self-management in a highly private, personalized manner.

Lynda has founded 3 tech startups and pioneered over 100 projects that have used digital media for the purposes of improving health, education and business. In senior roles with companies, including Edelman and Electronic Arts, Lynda has also represented Canada on two UN missions and authored national trade action plans and foundational documents for the sector.

Lynda was named Top 40 MM&M 2019, Startup Canada Entrepreneur of the Year 2017, Top 40 Under 40, Wondrous Wired Woman, and notably the Health 2.0 Global Challenge. She holds the title of Chair Emerita for Simon Fraser University and is a Director for the Canada Foundation for Innovation, which oversees a $763M fund for investment into R&D across Canada.

Dr Giovanna Jaramillo Gutierrez is a data science enthusiast and the Co-Founder of Milan & Associates – a social enterprise offering consultancy services in -and bridging across- the fields of change management, public health, ethics and artificial intelligence.

In parallel, she is a consultant, senior field epidemiologist for the World Health Organization, specialized in infection disease outbreak response such as Influenza and Ebola outbreaks. She carried out her PhD research on Malaria at the US National Institutes of Health jointly with the Université Libre de Bruxelles, and has a Master in Epidemiology from the London School of Hygiene & Tropical Medicine. She is an active member of the European Programme for Intervention Epidemiology Training Alumni Network. More recently, she joined the allwomen.tech community in Barcelona that promotes women in the tech sector.

Dr. Ozanan Meireles is a Bariatric, Foregut, and advanced endoluminal Surgeon at the Massachusetts General Hospital, and an Assistant Professor of Surgery at Harvard Medical School. He is the director of the Surgical Artificial Intelligence and Innovation Laboratory (SAIIL) at the Massachusetts General Hospital.

Dr. Meireles graduated from the Sao Paulo State University School of Medicine, in Brazil. He completed his surgical training at Michigan State University and his clinical fellowship in Minimally Invasive and Bariatric Surgery at the University of California San Diego. He spent his research fellowship at the Johns Hopkins Hospital investigating augmented reality in surgery and robotic telemanipulation. Furthermore, he was deeply involved in studying and developing Natural Orifices Trans Endoluminal Surgery (NOTES) techniques, and he was among the first to pioneer their clinical applications.

At SAIIL, his research focus is on utilizing computer vision to investigate the intraoperative phase of care through real-time, automated surgical analysis, and provide surgeons with additional data, with the goals of democratization of surgical knowledge, lowering costs, improve patient outcomes, and reduction of morbidity and mortality.

He is a fellow of the American College of Surgeons (ACS) and the American Society for Metabolic and Bariatric Surgery (ASMBS). He serves as the Chairman of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Artificial Intelligence Task Force. He also holds key leadership positions and committee memberships in several other national societies in the United States, including the ACS, NOSCAR, ASMBS, and SSAT.

Lars Maaløe holds a MS and PhD from the Technical University of Denmark in Machine Learning. Additionally, he carries extensive research and publication history in semi-supervised and unsupervised machine learning. In the past, Maaløe has worked with companies such as Issuu and Apple and currently works as the co-counder and CTO of Corti. By supplementing human intelligence with artificial intelligene, Corti is able to assist and augment medical professionals to help predict medical cases in real time and provide them with intelligent decision support. It allows them to arrive at a conclusion faster and to provide better- informed treatment.

Alex’s role at Holmusk is to build collaborations with academic, clinical and commercial partners in the UK and Europe.

He received his BSc in Biochemistry from the University of Kent and his PhD from the MRC Laboratory of Molecular Biology in Cambridge. Postdoctoral research on motor proteins and optical tweezers followed at the Whitehead Institute (MIT) and the University of York, UK.

Joining the UK’s National Physical Laboratory as a Senior Research Scientist, later a Principal Research Scientist, he led research on super-resolution and single-molecule microscopy techniques and on point of care clinical diagnostics. He also worked on international standardisation of biological measurement and spectroscopic methods for biopharmaceutical quality control. He has managed many collaborative research projects involving industry, academia and clinicians.

Recently he has been CEO of a start-up developing consumer microbiomics tests and analysing clinical trial data for a CRO. Alex has published over 45 papers and edited the book “Single Molecule Biology”. He is also a Fellow of the Royal Microscopical Society.

Stefan Suter is an expert in Value Base Healthcare and Founder & CEO of Curo-Health, a Swiss based company to drive efficiency increase across health care systems. With close to two decades of experience in health care industry both in Europe and Asia, he has a profound understanding of market dynamics and stakeholder interactions across nations.

Stefan Suter is passionate to center care around Patient Relevant Outcomes and use of Precision Medicine for more efficient delivery of care. During his career, he introduced a number of innovative solutions, such as digital health platforms, decision support systems, centers of excellence, diabetes clinics, real world evidence studies or risk sharing agreements for efficient use of therapies. Bringing together different expertise and working in diverse cultures and environments to solve real-world problems has always been his zest and asset.

Stefan Suter is an organizer of international health care forums and is a speaker at congresses and events. He holds a bachelor’s degree in economics and an MBA from University of Wales. He lives with his family in Switzerland and Singapore.

Dr Suman Paul (MBBS, MD, MRCP) is a specialist registrar in respiratory and general medicine, currently working in Warrington and Halton Hospitals NHS Foundation Trust, UK. He completed his graduation from Medical College, Kolkata, India and subsequently completed post graduate training in pulmonary medicine with special interest in interventional pulmonology. At present, he is pursuing higher specialty training in respiratory and general medicine in North west of England.

Dr Paul is experienced in interventional pulmonology procedures like bronchoscopy, endobronchial ultrasound, endobronchial stent insertion, bronchoscopic lung volume reduction procedures. He has keen interest in clinical research and have published articles in medical journals and presented his research findings in National and International conferences.

Jonathon Feit, is Co-Founder & Chief Executive of Beyond Lucid Technologies, a software firm that connects ambulances and hospitals prior to the patient’s arrival, and documents patients’ prehospital care over time. A widely published marketing expert focused on new media and the strategic use of information technology, In 2009, Jonathon was honored to serve as an MBA Intern in the White House Office of Management & Budget (Performance & Personnel Management division), where he helped spearhead the redesign and relaunch of USAJOBS.gov – the “Face of Federal Hiring.” He has presented before audiences including Health 2.0, the mHealth Summit, the Skolkovo Foundation (Moscow), Young Inventors International, and EMS trade events including ASPR NEXT, the International Roundtable on Community Paramedicine and the Northwest Arkansas Trauma Symposium. Jonathon’s poster on overlaps among trauma, CP/MIH and opioid / opiate / amphetamine diversion data was presented at the 2019 Society of Trauma Nurses annual meeting, and again at the 2019 AZ Rural Health conference. Jonathon is also Managing Consultant for the BrainTrust of Fire & EMS Technologists, which has advised on interoperability solutions and strategies for several U.S. states.

At Beyond Lucid Technologies, Jonathon has forged market-facing collaborations with Dell, AthenaHealth, Lockheed Martin, General Dynamics, Telamon, Conduent / Xerox Government Solutions, and other major corporations. He has led Beyond Lucid Technologies to profitability, acceptance into the CommonWell Health Alliance as its first EMS-facing member, and critical acclaim as winner of both the EMS World Innovation Award (2014) and JEMS Hot Product award (2015). BLT was the runner up for the 2018 East Bay Innovation Awards (IT & Communications category), and was most recently, named the 2019 Technology Award for Communications Techonlogy from the investment research firm Frost & Sullivan. Jonathon has been featured in Inc. Magazine, San Francisco Chronicle, and the Harvard Business Review. He is a member of the National Press Club, a columnist for the Journal of EMS (JEMS) and frequent contributor to EMS WORLD Magazine, with an extensive consumer business and trade publications list including EMS Director Magazine, Forbes.com, BusinessWeek.com, Mediabistro, Ad Age, 944 Los Angeles, and The Health Care Blog.

Jonathon has Tourette’s Syndrome and is passionate about advocating on behalf of people with disabilities. Concurrent with his professional activities, and following a short term in the U.S. Army Reserve, he engaged in scholarly research on the etiology and treatment of psychiatric disorders including Post-Traumatic Stress. He has presented original papers before the World Congress of Psychosomatic Medicine (2009) and the American Academy of Religion (2004), and edited a textbook chapter on the pharmacological treatment of epilepsy. Jonathon holds an MBA from Carnegie Mellon University’s Tepper School of Business, and a Combined BA/MA cum laude in “Psychology, Religion, and Conflict Negotiations” from Boston University. Jonathon earned graduate certificates in Mediation from the Straus Institute for Dispute Resolution at the Pepperdine School of Law, and in Entrepreneurship Development from the Sloan School of Management at the Massachusetts Institute of Technology.

Nearly 25 years driving strategy & commercialization efforts in Biotech, Pharma, and Enterprise Software with Fortune 500 Co’s such as Merck & Co, Eli Lilly & Biogen.
Ferdi’s focus is in Life Sciences (LS) strategic planning and industry marketing efforts for enterprise software solutions at OpenText today.
He is energized by strategies that deliver on their promises!

Dmitry Etin is the global Healthcare and Life Sciences Lead at Enterprise Content Services division of OpenText. Dmitry worked for 5 years as a hospital CIO and then moved to an IT industry as a solution consultant and an architect for eHealth solutions. He is advising various digital health startups and is a co-founder of an undiagnosed rare disease bioinformatics association under the Brigham Genomic Medicine Program.

Caitlin Pley is a policy associate with Women in Global Health and specialises in Universal Health Coverage. Together with colleagues from Women in Global Health and the Alliance for Gender Equality and UHC, she has advocated for gender equality in the health workforce and the inclusion of essential sexual and reproductive health services in UHC. Caitlin has a broad range of experience in global health, having worked on access to medicines with Médecins Sans Frontières, antimicrobial resistance with Public Health England, and palliative care policy with Chatham House. She is currently pursuing a medical degree from the University of Cambridge, where she also teaches pharmacology.

Aline is the Chief Learning Officer at Fondation Botnar. She studied Physics in Lausanne and earned her PhD in Surface Physics in Basel. She has broad experience in academia and industry, and understands what is needed to bring projects and solutions along from innovation to end-users with efficient project and product management. Her additional background in organisation development and leadership drives her to find the best balance between the human and the technical success factors in all projects. At Fondation Botnar she is responsible for the research and the changemaker portfolios as well as the monitoring, evaluation, strategic learning activities.

Uttara is a qualified healthcare expert. She initially trained and worked as a pathologist and later developed expertise in digital imaging solutions for the Healthcare and Life Sciences industries. Her specialties include a deep understanding of Artificial Intelligence applications and expertise in designing custom solutions and services that help increase workflow efficiency, accuracy and precision in the pre-clinical and clinical domains.

Jean-François Roy is CTO and co-founder of Carre Technologies since 2006. He leads the R&D company development to develop wearable biosensors and mobile applications. Hexoskin, our wearable body metrics device includes a garment textile sensors, an embedded electronic device, mobile applications and cloud computing. Jean-Francois has a strong background in R&D project analysis, risk assessment, and development. He is a specialist in embedded systems, an experienced ASIC, FPGA and board designer. He also developed signal processing algorithms in many programming languages. As CTO of Hexoskin for 10 years, he managed a team of 25 employees and 8 subcontractors. He’s been involved with the design, development, integration, and testing of the Hexoskin/Astroskin system and related biomedical technologies since 2006.

Geralyn Ochab spent over 20 years on technology’s cutting-edge in healthcare, while creating durable business partnerships across these spheres. She’s orchestrated market expansions, built high performance teams, and spearheaded full scale corporate restructures. Geralyn continues on this path as Imagia’s Chief Business Officer. At Imagia, Geralyn spearheads global B2B partnerships while ensuring that business success is backed by professional integrity.

In her previous roles, she served as Toshiba Canada’s Executive Business Manager, the National Ultrasound Sales and Marketing Manager at GE Healthcare, and Director of Business Development for Resonant Medical. Geralyn’s healthcare business acumen is burnished with over 20 years in medical imaging and a decade of clinical ultrasound expertise.

Performing at the highest level, Geralyn managed multi-million dollar sales budgets, seamless integration of corporate acquisitions, and achieved consistent, multi-year corporate growth in all business cycles. No matter the company’s size or challenges—from start-ups to blue chip corporations—Geralyn fostered environments rooted in performance, growth, and development.

With her service oriented spirit, Geralyn serves on the board for Parents Guide to Cord Blood Foundation.

Sanjay leads UK Partnerships at Owkin and is a practising physician (neurology). He holds degrees from Oxford and Cambridge Universities, and as well as Membership of the Royal College of Physicians. Prior to Owkin, he was a Senior Associate at Boston Consulting Group, where he focussed on data and digital in healthcare. He is a member of the Patient Safety Committee at the Royal Society of Medicine.